title: [Evaluation the curative effect of supracricoid partial laryngectomy for laryngeal cancer].
abstract: OBJECTIVE
  To analyze the oncological outcomes, functional outcomes in patients undergoing supracricoid partial laryngectomy (SCPL). Provide clinical experience for application of SCPL.
  
  
  METHODS
  A retrospective analysis of the 115 cases with laryngeal carcinoma accepted SCPL in our department from Jan 1996 to Dec 2004. Use the Kaplan-Meier method to analyze the patients'survival rate. Evaluate the value of reserve larynx function.
  
  
  RESULTS
  The 5-years survival rates and the decannulation rate was 80.8%, 99.1% respectively; and the average decannulation time was 22.25 days. The mean time of removal of gastric tube was 9.57 days. The function of CHEP was superior to CHP. The vocal function of 115 cases were all achieved in general communication.
  
  
  CONCLUSIONS
  SCPL get better oncological and functional outcomes and allows the preservation of the basic function of the larynx. It's a safe, effective technique and deserved to generalization.
authors.affiliation: Department of Otolaryngology, the Affiliated Second Hospital of Sun Yet-sen University, Guangzhou, 510120, China.
authors.forename: Suhong
authors.initials: S
authors.lastname: Huang
authors.forename: Zhong
authors.initials: Z
authors.lastname: Guan
authors.forename: Jieren
authors.initials: J
authors.lastname: Peng
authors.forename: Yuanshi
authors.initials: Y
authors.lastname: Jiang
authors.forename: Qingming
authors.initials: Q
authors.lastname: Li
authors.forename: Zhijian
authors.initials: Z
authors.lastname: Xu
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003413:Cricoid Cartilage / Q000601:surgery*; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome